Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Methotrexate and psoriasis].

I Bournerias1

  • 1Service de dermatologie, hôpital Henri-Mondor, Créteil.

La Revue Du Praticien
|October 15, 1991
PubMed
Summary
This summary is machine-generated.

Methotrexate effectively treats severe psoriasis when used at low doses according to guidelines. While generally safe, potential risks include cumulative liver damage (hepatotoxicity) and blood disorders (hematologic toxicity), particularly when combined with other drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Furuncular myiasis].

Annales de dermatologie et de venereologie·2006
Same author

Rapid improvement of chronic interstitial keratitis with acitretin.

The British journal of ophthalmology·2002
Same author

Hepatitis C virus infection in cutaneous polyarteritis nodosa: a retrospective study of 16 cases.

Archives of dermatology·1999
Same author

[Pigmented nodular tenosynovitis. A misdiagnosed etiology of isolated tumefaction of fingers or toes].

Annales de dermatologie et de venereologie·1998
Same author

Tinea capitis in adults: misdiagnosis or reappearance?

Dermatology (Basel, Switzerland)·1997
Same author

Unusual Microsporum canis infections in adult HIV patients.

Journal of the American Academy of Dermatology·1996
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Dermatology
  • Pharmacology
  • Toxicology

Background:

  • Severe psoriasis requires effective systemic treatments.
  • Methotrexate is a commonly used systemic agent for psoriasis.
  • Understanding methotrexate's safety profile is crucial for patient management.

Purpose of the Study:

  • To evaluate the efficacy of methotrexate in severe psoriasis.
  • To assess the safety and adverse effects of methotrexate therapy.
  • To identify risk factors for methotrexate-associated toxicity.

Main Methods:

  • Review of clinical data on patients with severe psoriasis treated with methotrexate.
  • Analysis of adverse event reports, focusing on hepatotoxicity and hematologic toxicity.
  • Assessment of adherence to recommended dosing guidelines.

Related Experiment Videos

Main Results:

  • Methotrexate demonstrates significant efficacy in managing severe psoriasis.
  • Low-dose methotrexate, when administered according to guidelines, is associated with a manageable safety profile.
  • Cumulative hepatotoxicity is the primary long-term adverse effect.
  • Hematologic toxicity is more prevalent when methotrexate is co-administered with other medications.

Conclusions:

  • Methotrexate is a valuable and effective treatment option for severe psoriasis.
  • Strict adherence to established guidelines minimizes the risks associated with methotrexate therapy.
  • Vigilance for cumulative hepatotoxicity and potential drug interactions leading to hematologic toxicity is essential.